
US plan to impose a 100% tariff on imported generic medicines from 2028 raises concerns for Indian drugmakers, but the industry says it has time to adapt. Highlights Story India’s pharmaceutical industry is closely monitoring the US administration’s proposal to impose a 100% tariff on imported generic medicines from 2028....









